{"id":1627,"date":"2024-06-11T13:26:12","date_gmt":"2024-06-11T13:26:12","guid":{"rendered":"https:\/\/novaptech.com\/?page_id=1627"},"modified":"2025-02-28T13:07:47","modified_gmt":"2025-02-28T13:07:47","slug":"biomarker-analysis-novaptech-2","status":"publish","type":"page","link":"https:\/\/novaptech.com\/en\/biomarker-analysis-novaptech-2\/","title":{"rendered":"Biotechnology laboratory | Novaptech"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Novaptech, a cutting-edge biotechnology laboratory !<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Specialized in the development of aptamers, our company is firmly committed to research and development to explore new frontiers in ligand science.
Our contribution to biotechnology reflects our commitment to solving complex challenges in health, food safety and environment and beyond, and to positioning ourselves as an innovative player in the biotech world.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Learn about the innovative aptamer technology and the selection process through aptamer SELEX. Compare the effectiveness of aptamers vs antibodies, and explore detailed insights into biomarker analysis and cutting-edge techniques in biomarker analysis.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Key advantages of Aptamers over Antibodies<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Aptamers are synthetic molecules that can be raised against any kind of target, including toxic or non-immunogenic ones. They bind their target with affinity similar or higher than antibodies. They are 10 fold smaller than antibodies and can be chemically-modified at will in a defined and precise way. They can be easily stored and delivered ; they can be reversibly heat-denatured and renatured. The sourcing is guaranteed with a total batch to batch reproducibility.<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

They can be used under non physiological conditions for analytical purposes.<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

They are non\u2013immunogenic and can be used in vivo.<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\"Aptamers<\/figure><\/div>\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tNovaptech's aptamer services<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Any question ? Contact us<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Any question about selection service or assay development ? Please fill in the form below with relevant details for helping us providing an informative answer. Telephone or video call can be arranged. NDA can be signed, would you wish so. We will answer you as quickly as possible (generally less than 2 working days).<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tContact us<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Biomarker\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Your scientific contact :<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Jean-Jacques Toulm\u00e9, PhD, CSO<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t<\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tAptamers : a new vision of biotechnology !<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

Aptamers are oligonucleotides that bind to specific targets with high affinity.
At Novaptech, we exploit this unique ability, making them essential for medical and life
sciences research and analytical applications. Aptamers offer a genuinely advantageous
alternative to antibodies.
Thanks to their high specificity, stability under a variety of conditions and cheaper production,
aptamers are accelerating innovation in diagnostics, disease treatment and analytical
chemistry\/biochemistry. Their flexibility and adaptability open up new prospects for
personalized therapies and precision medicine.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t<\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tNovaptech : aptamers in response to biomedical challenges<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

Novaptech’s close to 30 year experience in the biotech field is recognized by its in-depth
expertise in the customized selection of aptamers, the characterization of these molecules and
their innovative application in various sectors.
Novaptech’s services encompass the tailor-made development of aptamers to specifically
target molecules or cells of interest, offering key solutions for biomedical research, clinical
diagnostics and analytical applications.
Our company leverages its expertise in molecular biology, bioinformatics and molecular
biophysics to deliver aptamers with optimal binding properties that facilitate precise pathogen
detection, drug formulation and the study of complex molecular interactions.
Our personalized approach, together with our research and development department,
positions Novaptech as a privileged partner for academic institutions, the pharmaceutical,
biotechnology, edible or environmental industries wishing to exploit the potential of aptamers
in their projects.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t<\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tServices offered by our cellular and molecular biotechnology laboratory<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

Thanks to our expertise in the identification and characterization of aptamers for the
biotechnological development of analytical and diagnostic aptamer projects, the world of
biotechnology is undergoing a revolution thanks to Novaptech.
We excel in the selection, optimization and development of customized aptamers, enabling
us to offer innovative solutions and tests to a wide range of players in the pharmaceutical, agri\u0002food and cosmetics industries, through our range of test kits and rapid diagnostics.<\/p>

Selection and characterization of customized aptamers<\/strong><\/p>

At Novaptech, we have the ability to develop customized aptamers specific of a variety of
targets, whether synthetic molecules, peptides, proteins, bacteria or even eukaryotic cells.
Our expertise in aptamer selection and characterization is tailored to a wide range of needs<\/p>

Aptamer optimization and development of Aptamer-based assays<\/strong><\/p>

Once we’ve identified an aptamer, we don’t stop there.
Our research teams carry out a rigorous optimization of its sequence, truncating it to the strict
minimum required and introducing specific modifications to improve its performance.
What’s more, we are able to conjugate it to various functional groups such as thiol, carboxyl,
amine or fluorophores, depending on the requirements of the intended application, whether for
imaging, biodetection, affinity purification or many other fields.<\/p>

Structure-switching aptamers for multiplex assays<\/strong><\/p>

At Novaptech, we’ve taken innovation a step further by developing functional structure\u0002switching aptamers based on our revolutionary “NOVAswitch\u201d technology.
This approach is particularly powerful for the detection of small molecules, whether
contaminants, drugs, biomarkers or nutrients. Thanks to this technology, we can perform
multiplex tests with extreme precision and sensitivity.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t<\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tNovaptech: a key player in the world of biotechnology<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

Novaptech stands out as a leading player in cellular and molecular biotechnology techniques, with about 30 years of expertise in the field of aptamers.
Novaptech’s strength lies in our commitment to collaboration and scientific excellence, making us an invaluable partner for researchers and companies in the sector.<\/p>

Personalized support from conception to completion<\/strong><\/p>

From the very start of your project, Novaptech offers you personal interaction with one of our experienced scientists. This enables us to assess feasibility, design a suitable library and tailor a selection procedure.
In addition, Novaptech guides you in defining the necessary chemical modifications and the ideal assay for your application.
Constructive feedback is provided at every stage of your project to ensure its success.<\/p>

Cutting-edge aptamer technologies : “NOVAswitch\u201d<\/strong><\/p>

Innovation is at the heart of Novaptech’s actions, with R&D researchers working on cutting-edge aptamer selection processes. Our “NOVAswitch\u201d technology is a revolution that we place at the heart of our activities for the new perspectives it offers for the design of biosensors for diagnostic and analytical applications.<\/p>

Fiscal support for French research<\/strong><\/p>

Novaptech has received certification for the French research tax credit for the years 2020 to 2024. Our customers benefit from a refundable tax credit for research and development services entrusted to our laboratory. This makes us even more attractive for research projects in France.<\/p>

A strategic partnership with Eurogentec<\/strong><\/p>

To meet our customers’ aptamer production needs, Novaptech has established a strategic partnership with Eurogentec, a world leader in custom oligonucleotide production.
https:\/\/www.eurogentec.com\/en\/oligos-aptamers<\/a><\/p>

This collaboration provides access to small- and large-scale industrial synthesis capacities including under GMP conditions, further strengthening Novaptech’s position as a leader in the field of cellular and molecular biotechnologies, and in particular aptamers.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Novaptech, a cutting-edge biotechnology laboratory ! Specialized in the development of aptamers, our company is firmly committed to research and development to explore new frontiers in ligand science. Our contribution to biotechnology reflects our commitment to solving complex challenges in health, food safety and environment and beyond, and to positioning ourselves as an innovative player in the biotech world. Learn about the innovative aptamer technology and the selection process through aptamer SELEX. Compare the effectiveness of aptamers vs antibodies, and explore detailed insights into biomarker analysis and cutting-edge techniques in biomarker analysis. Key advantages of Aptamers over Antibodies Aptamers are synthetic molecules that can be raised against any kind of target, including toxic or non-immunogenic ones. They bind their target with affinity similar or higher than antibodies. They are 10 fold smaller than antibodies and can be chemically-modified at will in a defined and precise way. They can be easily stored and delivered ; they can be reversibly heat-denatured and renatured. The sourcing is guaranteed with a total batch to batch reproducibility. They can be used under non physiological conditions for analytical purposes. They are non\u2013immunogenic and can be used in vivo. Novaptech’s aptamer services Any question ? Contact us Any question about selection service or assay development ? Please fill in the form below with relevant details for helping us providing an informative answer. Telephone or video call can be arranged. NDA can be signed, would you wish so. We will answer you as quickly as possible (generally less than 2 working days). Contact us Your scientific contact : Jean-Jacques Toulm\u00e9, PhD, CSO Aptamers : a new vision of biotechnology ! Aptamers are oligonucleotides that bind to specific targets with high affinity. At Novaptech, we exploit this unique ability, making them essential for medical and life sciences research and analytical applications. Aptamers offer a genuinely advantageous alternative to antibodies. Thanks to their high specificity, stability under a variety of conditions and cheaper production, aptamers are accelerating innovation in diagnostics, disease treatment and analytical chemistry\/biochemistry. Their flexibility and adaptability open up new prospects for personalized therapies and precision medicine. Novaptech : aptamers in response to biomedical challenges Novaptech’s close to 30 year experience in the biotech field is recognized by its in-depth expertise in the customized selection of aptamers, the characterization of these molecules and their innovative application in various sectors. Novaptech’s services encompass the tailor-made development of aptamers to specifically target molecules or cells of interest, offering key solutions for biomedical research, clinical diagnostics and analytical applications. Our company leverages its expertise in molecular biology, bioinformatics and molecular biophysics to deliver aptamers with optimal binding properties that facilitate precise pathogen detection, drug formulation and the study of complex molecular interactions. Our personalized approach, together with our research and development department,positions Novaptech as a privileged partner for academic institutions, the pharmaceutical, biotechnology, edible or environmental industries wishing to exploit the potential of aptamersin their projects. Services offered by our cellular and molecular biotechnology laboratory Thanks to our expertise in the identification and characterization of aptamers for the biotechnological development of analytical and diagnostic aptamer projects, the world of biotechnology is undergoing a revolution thanks to Novaptech. We excel in the selection, optimization and development of customized aptamers, enabling us to offer innovative solutions and tests to a wide range of players in the pharmaceutical, agri\u0002food and cosmetics industries, through our range of test kits and rapid diagnostics. Selection and characterization of customized aptamers At Novaptech, we have the ability to develop customized aptamers specific of a variety of targets, whether synthetic molecules, peptides, proteins, bacteria or even eukaryotic cells. Our expertise in aptamer selection and characterization is tailored to a wide range of needs Aptamer optimization and development of Aptamer-based assays Once we’ve identified an aptamer, we don’t stop there. Our research teams carry out a rigorous optimization of its sequence, truncating it to the strict minimum required and introducing specific modifications to improve its performance. What’s more, we are able to conjugate it to various functional groups such as thiol, carboxyl, amine or fluorophores, depending on the requirements of the intended application, whether for imaging, biodetection, affinity purification or many other fields. Structure-switching aptamers for multiplex assays At Novaptech, we’ve taken innovation a step further by developing functional structure\u0002switching aptamers based on our revolutionary “NOVAswitch\u201d technology. This approach is particularly powerful for the detection of small molecules, whether contaminants, drugs, biomarkers or nutrients. Thanks to this technology, we can perform multiplex tests with extreme precision and sensitivity. Novaptech: a key player in the world of biotechnology Novaptech stands out as a leading player in cellular and molecular biotechnology techniques, with about 30 years of expertise in the field of aptamers. Novaptech’s strength lies in our commitment to collaboration and scientific excellence, making us an invaluable partner for researchers and companies in the sector. Personalized support from conception to completion From the very start of your project, Novaptech offers you personal interaction with one of our experienced scientists. This enables us to assess feasibility, design a suitable library and tailor a selection procedure. In addition, Novaptech guides you in defining the necessary chemical modifications and the ideal assay for your application.Constructive feedback is provided at every stage of your project to ensure its success. Cutting-edge aptamer technologies : “NOVAswitch\u201d Innovation is at the heart of Novaptech’s actions, with R&D researchers working on cutting-edge aptamer selection processes. Our “NOVAswitch\u201d technology is a revolution that we place at the heart of our activities for the new perspectives it offers for the design of biosensors for diagnostic and analytical applications. Fiscal support for French research Novaptech has received certification for the French research tax credit for the years 2020 to 2024. Our customers benefit from a refundable tax credit for research and development services entrusted to our laboratory. This makes us even more attractive for research projects in France. A strategic partnership with Eurogentec To meet our customers’ aptamer production needs, Novaptech has established a strategic partnership with Eurogentec, a world leader<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-1627","page","type-page","status-publish","hentry"],"yoast_head":"\nBiotechnology laboratory | Novaptech - Novaptech<\/title>\n<meta name=\"description\" content=\"Specialized in the development of aptamers, our company is firmly committed to research and development to explore new frontiers in ligand science.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaptech.com\/en\/biomarker-analysis-novaptech-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biotechnology laboratory | Novaptech - Novaptech\" \/>\n<meta property=\"og:description\" content=\"Specialized in the development of aptamers, our company is firmly committed to research and development to explore new frontiers in ligand science.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaptech.com\/en\/biomarker-analysis-novaptech-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Novaptech\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-28T13:07:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/\",\"url\":\"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/\",\"name\":\"Biotechnology laboratory | Novaptech - Novaptech\",\"isPartOf\":{\"@id\":\"https:\/\/novaptech.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg\",\"datePublished\":\"2024-06-11T13:26:12+00:00\",\"dateModified\":\"2025-02-28T13:07:47+00:00\",\"description\":\"Specialized in the development of aptamers, our company is firmly committed to research and development to explore new frontiers in ligand science.\",\"breadcrumb\":{\"@id\":\"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/#primaryimage\",\"url\":\"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg\",\"contentUrl\":\"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/novaptech.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biotechnology laboratory | Novaptech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/novaptech.com\/en\/#website\",\"url\":\"https:\/\/novaptech.com\/en\/\",\"name\":\"Novaptech\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/novaptech.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/novaptech.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/novaptech.com\/en\/#organization\",\"name\":\"Novaptech\",\"url\":\"https:\/\/novaptech.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/novaptech.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/06\/cropped-LOGO.png\",\"contentUrl\":\"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/06\/cropped-LOGO.png\",\"width\":335,\"height\":140,\"caption\":\"Novaptech\"},\"image\":{\"@id\":\"https:\/\/novaptech.com\/en\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biotechnology laboratory | Novaptech - Novaptech","description":"Specialized in the development of aptamers, our company is firmly committed to research and development to explore new frontiers in ligand science.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaptech.com\/en\/biomarker-analysis-novaptech-2\/","og_locale":"en_US","og_type":"article","og_title":"Biotechnology laboratory | Novaptech - Novaptech","og_description":"Specialized in the development of aptamers, our company is firmly committed to research and development to explore new frontiers in ligand science.","og_url":"https:\/\/novaptech.com\/en\/biomarker-analysis-novaptech-2\/","og_site_name":"Novaptech","article_modified_time":"2025-02-28T13:07:47+00:00","og_image":[{"url":"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/","url":"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/","name":"Biotechnology laboratory | Novaptech - Novaptech","isPartOf":{"@id":"https:\/\/novaptech.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/#primaryimage"},"image":{"@id":"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/#primaryimage"},"thumbnailUrl":"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg","datePublished":"2024-06-11T13:26:12+00:00","dateModified":"2025-02-28T13:07:47+00:00","description":"Specialized in the development of aptamers, our company is firmly committed to research and development to explore new frontiers in ligand science.","breadcrumb":{"@id":"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/#primaryimage","url":"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg","contentUrl":"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/05\/thumb_600_400_0_0_crop-1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/novaptech.com\/biomarker-analysis-novaptech-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/novaptech.com\/en\/"},{"@type":"ListItem","position":2,"name":"Biotechnology laboratory | Novaptech"}]},{"@type":"WebSite","@id":"https:\/\/novaptech.com\/en\/#website","url":"https:\/\/novaptech.com\/en\/","name":"Novaptech","description":"","publisher":{"@id":"https:\/\/novaptech.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/novaptech.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/novaptech.com\/en\/#organization","name":"Novaptech","url":"https:\/\/novaptech.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/novaptech.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/06\/cropped-LOGO.png","contentUrl":"https:\/\/novaptech.com\/wp-content\/uploads\/2024\/06\/cropped-LOGO.png","width":335,"height":140,"caption":"Novaptech"},"image":{"@id":"https:\/\/novaptech.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/novaptech.com\/en\/wp-json\/wp\/v2\/pages\/1627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/novaptech.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/novaptech.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/novaptech.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/novaptech.com\/en\/wp-json\/wp\/v2\/comments?post=1627"}],"version-history":[{"count":30,"href":"https:\/\/novaptech.com\/en\/wp-json\/wp\/v2\/pages\/1627\/revisions"}],"predecessor-version":[{"id":4371,"href":"https:\/\/novaptech.com\/en\/wp-json\/wp\/v2\/pages\/1627\/revisions\/4371"}],"wp:attachment":[{"href":"https:\/\/novaptech.com\/en\/wp-json\/wp\/v2\/media?parent=1627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}